Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability Ancrenaz, Virginie; Daali, Youssef; Fontana, Pierre; Besson, M.; ... Desmeules, Jules Alexandre 2010
add to browser selection
Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients Daali, Youssef; Ancrenaz, Virginie; Bosilkovska Weisskopf, Marija; Dayer, Pierre; Desmeules, Jules Alexandre 2011
add to browser selection
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro Ancrenaz, Virginie; Desmeules, Jules Alexandre; James, Richard William; Fontana, Pierre; ... Daali, Youssef 2012
add to browser selection
Inhibiteurs des récepteurs plaquettaires P2Y12 à l'ADP: importance du métabolisme et influence des interactions médicamenteuses sur leurs paramètres pharmacocinétiques Ancrenaz, Virginie 2012
add to browser selection
Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers Ancrenaz, Virginie; Deglon, Julien; Samer, Caroline Flora; Staub, Christian Olivier; ... Desmeules, Jules Alexandre 2013
add to browser selection
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites Marsousi, Niloufar; Daali, Youssef; Fontana, Pierre; Reny, Jean-Luc; ... Samer, Caroline Flora 2018